Retinitis Pigmentosa and Stem Cells: New Clinical Trial


At University of California Irvine (UCI) are seeking participants to be enrolled in the first clinical trial to test the use of retinal progenitor stem-cells to treat retinitis pigmentosa. cellule staminali

This trial is an open-label phase 1/2a trial, designed to evaluate the safety of the retinal progenitor cells injected into the vitreous cavity at 2 different dosage levels in patients with late-stage retinitis pigmentosa.

Today 4 patients have received intra-vitreal cell injections. Total study participants will be 16 patients, followed for 12 months.
First results will be available in 12/24 months. As soon as results will become available we will post an update. Dr Badala keeps collaborating with Researchers at University of California Los Angeles (UCLA)


You might also be interested in the following news on similar topics: